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Overview: Sporotrichosis is an important
subcutaneous fungal infection of humans and
animals in some endemic tropical and
subtropical areas. Among domestic species,
cats are the most frequently infected. 
Infection: The primary mode of transmission 
is traumatic inoculation of fungal conidia from
plants and soil. Contact with infected cats is the
major mode of transmission to humans,
especially in endemic areas like Brazil, where a
large epidemic has occurred in the past decade. 
Disease signs: Most cases in cats are
cutaneous, presenting as multiple ulcerated
nodules and draining tracts in the skin.
Lymphadenopathy, respiratory signs and
systemic dissemination may also occur. 
Diagnosis Diagnosis is based on fungal
detection by cytology and/or histology, and
confirmation by culture. 
Treatment: Treatment consists of at least 
2 months’ systemic antifungal therapy, with
itraconazole as the first-choice agent. 
The prognosis is favourable provided there 
is good owner compliance and adverse drug
effects do not occur. 
Prevention: Contact with infected cats carries 
a high zoonotic risk. Cat owners travelling to
endemic areas should be warned and advised 
to keep their cats indoors to prevent infection.
Professionals must wear gloves when handling
cats with skin nodules and ulcers and dealing
with diagnostic samples.
Agent properties
Sporotrichosis is a deep cutaneous mycosis caused by the dimorphic
saprophytic fungus Sporothrix schenckii (a 3–5 µm wide, 5–9 µm long,
pleomorphic, round, oval or cigar-shape yeast). Many mammalian
species – including horses, camels, cattle and swine, as well as dogs
and cats – can be infected. Feline infection was first reported in 1971.1
The fungus exists as a hyphal or mycelial form at environmental
temperatures below 37ºC and as a yeast form at body temperature.
Several subtypes have been recognised using molecular techniques,
but – in humans – these are not correlated with the various clinical 









S schenckii is found
worldwide in soil,
wood, living plants and
decaying plant material. Human infections are caused by traumatic
inoculation of contaminated soil or organic material (sphagnum moss,
hay bales, mould, plant thorns, wood splinters), especially in forestry
workers, but also after contact with animals (fish spines, squirrel bites,
armadillo scratches, and draining lesions and scratches of infected cats
or dogs).4 Many humans are thought to have been infected by cats –
even healthy cats that have been in contact with infected cats may pose
a risk, as their oral samples have tested culture positive.5
Both human and animal disease is rare in Europe,6 the USA7,8 and
Japan;9 cases have been described in particular areas (eg, in the Apulia
region in Italy, and southeastern and southwestern USA). In a recent
European Advisory Board on Cat Diseases
The European Advisory Board on Cat Diseases (ABCD) is
a body of experts in immunology, vaccinology and clinical
feline medicine that issues guidelines on prevention and
management of feline infectious diseases in Europe, for
the benefit of the health and welfare of cats. The
guidelines are based on current scientific knowledge of
the diseases and available vaccines concerned.
The latest version of the sporotrichosis in cats
guidelines is available at www.abcd-vets.org
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retrospective study of 23 cases in various
mammalian species in California, the cat was
the most commonly affected (14 out of the 23
cases).10 In Central and South America, how-
ever, sporotrichosis represents the most com-
mon deep mycosis. In Brazil it is endemic, and
an important epidemic outbreak affecting
humans, cats and dogs has been reported
from Rio de Janeiro.2,5,11 
The disease in cats is mainly reported in
free-roaming intact males.12 Presumably, most
infections occur when the fungus is inoculat-
ed into a bite or scratch wound from an infect-
ed cat. The fungus can be isolated from
claws13 and skin lesions (Figure 1), but also,
importantly, from the nasal and oral cavities.11
Pathogenesis
Infection occurs through contact or skin punc-
ture wounds at the inoculation site, and there
may be local propagation. Infection spreads
via the regional lymphatic system, producing
lymphangitis and lymphadenitis.4 On rare
occasions, mainly in immunocompromised
patients, the infection may disseminate sys-
temically.
Clinical presentation 
Sporotrichosis has three clinical forms in cats:
cutaneous, cutaneolymphatic and disseminated.
In the cutaneous form, there are multiple,
ulcerated and crusted nodules, draining tracts
and abscesses or cellulitis on the head (Figure
2), limbs (Figures 3 and 4) and tail-base
region, reflecting common areas for bites and
scratches during fights. In some cases, these
lesions may become necrotic, exposing under-
lying tissues.10,14 Although most cases of 
generalised cutaneous lesions arise from
haematogenous spread, dissemination (eg, to
the paws, limbs and ears) may follow
autoinoculation during grooming.4
Lymphatic involvement may not be clinical-
ly evident, but can be demonstrated histologi-
cally, either in biopsies or necropsy
samples.10,14
Many organs may be affected in disseminat-
ed cases, the lungs and liver being preferred
sites.10,15 Widespread cutaneous lesions typi-
cally arise from haematogenous dissemination
after a primary respiratory infection. In these
cases, the fungus can be cultured from blood.
Systemic signs are non-specific and include
lethargy, anorexia and fever. Respiratory signs
occur in about one-third of cases, representing
the most frequent non-cutaneous sign.14,16
Sneezing has been reported in infected cats, in
which the fungus was isolated from nasal
mucosa.16
Some cats with disseminated disease have
been found to be infected with feline immuno -
deficiency virus (FIV), but immunosuppression
is not required for infection or clinical manifes-
tation of the disease. Some FIV-positive cats
affected with sporotrichosis have been treated,
with complete resolution of the fungal lesions.14
Blood abnormalities (anaemia, leukocytosis,
neutrophilia, hyperglobulinaemia and hypo -
albuminaemia) reported in cats with feline
sporotrichosis are non-specific, and consistent







Figure 1 Ulcerative lesions around the claw in a cat with
sporotrichosis. Courtesy of Dr Larsson, São Paulo, Brazil
Figure 2 Ulcerative crusted facial lesions in a cat
with sporotrichosis. Courtesy of Dr Larsson, São
Paulo, Brazil
Figure 3 Multiple ulcerative crusted lesions on the
forelimb of a cat with sporotrichosis. Courtesy of 
Dr Larsson, São Paulo, Brazil
Figure 4 Ulcerative lesions on the hind limb 
of a cat with sporotrichosis.  Courtesy of Dr Larsson,
São Paulo, Brazil
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Diagnosis 
Although uncommon in Europe, sporo -
trichosis should be included in the differential
diagnosis of nodular and/or ulcerative skin
disease with draining tracts. This is particu -
larly true for outdoor (fighting) cats, if a bac -
terial cause was initially suspected but the
response to antibiotic treatment was poor,
and/or the cat comes from an endemic area.
The fungus may be demonstrated by cytol-
ogy and/or histology, with confirmation by
fungal culture. 
Cytology
Smears from draining tracts and ulcers or fine
needle aspirates from nodules or ulcers should
always be obtained. Stained samples (eg,
Romanowsky) should be examined carefully for
yeast-like organisms. Special stains (eg, period-
ic acid-Schiff [PAS]) may help to visualise and
confirm the presence of fungi. Some authors
report easy identification in exudates from cats,
while others have found this difficult.4,10 Good
sensitivity (78.9%) of cytological examination as
compared with culture has recently been report-
ed in a study of 806 cats [EBM grade III].17
S schenckii appears to be mainly intracellular,
residing within macrophages and inflammato-
ry cells, but may sometimes also be found
extracellularly. Suspicious samples should be
submitted for confirmatory fungal culture.
Fungal culture
Culture is the confirmatory test of choice.18
Only a few organisms may be present in the
lesions, and exudate samples are best collect-
ed from the deep areas of the draining
tracts/ulcers.4,17 Preferably, a piece of tissue
should be submitted to the laboratory to avoid
false-negative results. Blood culture is recom-
mended if the disseminated form is suspect-
ed.19 S schenckii has also been cultured from
nasal swabs and bronchoalveolar lavage sam-
ples in cats with respiratory signs.16
Drug Dose and frequency Comments
Itraconazole 10 mg/kg q24h PO Suggested treatment of choice; continue for




2.5–20 mg/kg q24h PO
Clinical adverse effects, mainly
hepatotoxicity, may occur in many cats
Alternative if adverse effects or lack of
efficacy to itraconazole
Terbinafine 30 mg/cat q24h PO May be used in combination with
itraconazole
Consider if adverse effects or lack of
efficacy to itraconazole 
Fluconazole 50 mg/cat q24h PO Consider if disseminated infection
May be used in combination with itraconazole
Treatment of sporotrichosisTable 1
Histology
Histopathology is useful for the diagnosis of
sporotrichosis in cases with intact nodules.
The histological pattern is similar to that seen
in other fungal infections, with a nodular to
diffuse pyogranulomatous inflammatory
reaction involving the dermis and subcuta-
neous tissues, and sometimes extending into
deeper tissues.10 The organisms, which are
usually inside macrophages, may be numer-
ous and readily visualised upon haema-
toxylin-eosin staining (Figure 5); when they
are scarce, special PAS staining is necessary to
improve sensitivity.10 
Other tests
Recently, an ELISA for the detection of 
S schenckii antibodies has been evaluated, 
showing good sensitivity and specificity 
(over 90%); it may serve as a screening tool for
feline sporotrichosis [EBM grade I].20 The 
PCR has been successfully used to identify 
S schenckii in biopsy samples.21
Treatment 
Prospective studies on the treatment of feline
sporotrichosis do not exist, and all informa-
tion stems from retrospective studies and case
reports. 
Itraconazole is the treatment of choice 
(Table 1) [EBM grade III].10,18 Treatment should
be continued 1 month beyond clinical cure,
which means that the drug needs to be admin-
istered for more than 2 months. Itraconazole is
potentially hepatotoxic; cat owners should be
warned about clinical signs suggestive of
hepatic disease, and monthly monitoring of
serum liver enzymes is recommended. 
A supersaturated solution of potassium
iodide given orally is the treatment of choice
for sporotrichosis in dogs; it has also been
used in cats, where hepatotoxic effects are
Figure 5 Pyogranulomatous inflammatory reaction showing
numerous Sporothrix organisms within macrophages












for grading the level
of evidence of
various statements
within this article is
described on 
page 533 of this
Special Issue.
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Close feline contacts are a potential source of zoonotic infection. In recent
years, a growing number of human cases have been described, which have
occurred after contact with sick infected and healthy carrier cats in countries
where disease is endemic, such as Brazil or India.28–30 A genuine epidemic of
human sporotrichosis associated with transmission by cats has occurred in
Brazil over the past decade.31 Today, this route of human infection is consid-
ered significant, and more common than vegetal or organic environmental
sources. Cats are more efficient transmitters than other animals, presumably
because larger amounts of the fungus are present in tissues,
exudates and even faeces, and the infection may be trans-
mitted even in the absence of penetrating skin lesions.7
Veterinarians and persons handling infected cats are
at a high risk of acquiring the infection. It is recom-
mended that disposable gloves are always worn
when handling cats with any kind of ulcerated, drain-




handling infected cats are at
high risk of acquiring S schenckii
infection (sporo trichosis).
more likely to develop. However, a recent
observational study in 48 cats treated with
oral potassium iodide in capsules (variable
doses from 2.5–20 mg/kg q24h) showed a suc-
cess rate of 47.9%; also, fewer adverse effects
compared with previous studies were seen,
and this drug might serve as an alternative to
itraconazole [EBM grade III].22
Ketoconazole, commonly used in dogs as an
alternative to potassium iodide, has also been
used in cats, but adverse hepatic effects are
more frequent compared with itraconazole.23
Recent reports have demonstrated the effi-
cacy of terbinafine (allylamine derivative) in
people with sporotrichosis.24 As it showed
good efficacy in vitro,25 this drug might be 
an alternative for the treatment of cats that do
not tolerate itraconazole, in cases that respond
poorly, and/or if an azole resistance is sus-
pected [EBM grade IV]. 
In a large retrospective study in Brazil, 
various regimens and combinations of anti-
fungals, including itraconazole plus potassi-
um iodide, itraconazole plus fluconazole,
itraconazole plus terbinafine, and ketocona-
zole alone, were examined. About one-fifth of
the cats were cured (68/347); in the others
some clinical improvement was observed.15
In a retrospective study in California, most
cats were successfully treated with itracona-
zole; in two cases treated with iodide deriva-
tives and one case of disseminated disease
treated with fluconazole the infection was
controlled [EBM grade III].10
Successful intralesional amphotericin B
treatment was documented in a single case
report, and in a series of 26 cats (in combina-
tion with itraconazole) to treat refractory skin
disease [EBM grade III].26,27
Concurrent bacterial infection, which is
common, must be treated with an appropriate
antibiotic for 1–2 months.4
< Sporotrichosis is an important subcutaneous infection of humans and animals. Cats are most frequently infected.
< Sporotrichosis is endemic in some tropical and subtropical areas; it is particularly frequent in Brazil, but has been
diagnosed in certain areas of Europe, North America and Japan.
< The zoonotic risk is high, through contact with infected cats, which can be healthy carriers.
< Sporotrichosis should be included in the list of differential diagnoses for cats with multiple ulcerated nodules,
ulcers and draining tracts, especially in ‘fight and bite’ locations.
< Diagnosis is based on recognition of the fungus in cytology or histology samples and confirmation by culture.
< Itraconazole is the first choice for treatment. Other antifungals may be helpful: potassium iodide in capsules,
fluconazole, amphotericin B and combinations. 
< Treatment should be extended for 1 month after resolution of the lesions.
< Owner compliance is the most important factor in determining the prognosis.
< Cat owners travelling to endemic areas must be warned about the disease. Veterinarians dealing 
with infected or suspicious cats must use preventive measures to avoid infection.
KEY POINTS
Prognosis 
The prognosis is usually good, if treatment
duration and owner compliance are ade-
quate.10,14 However, it is poor in disseminated
infections and/or if treatment is discontinued
before the end of the recommended regimen.14 
Prevention
As a preventive measure, cats should be kept
indoors in endemic areas to avoid contact
with infected or carrier cats; this is especially
important in immunocompromised animals
(eg, retrovirus-infected cats or those receiving
immunosuppressive drugs). Owners moving
to endemic areas, like Central and South
America, should be warned about sporotri-
chosis, especially if cats will be allowed to
have access to outdoors. 
Zoonot ic r isk
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